|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/19/2024 |
$1.40 |
$1.44 |
$1.36 |
$1.40 |
58.80K | 04/22/2024 |
$1.39 |
$1.50 |
$1.39 |
$1.44 |
130.60K | 04/23/2024 |
$1.43 |
$1.57 |
$1.43 |
$1.53 |
137.40K | 04/24/2024 |
$1.60 |
$1.60 |
$1.49 |
$1.51 |
90.60K | 04/25/2024 |
$1.47 |
$1.52 |
$1.41 |
$1.48 |
66.30K |
|
Corvus Pharmaceuticals is a clinical stage biopharmaceutical company focused on the development of immune modulator product candidates to treat solid cancers, T-cell lymphomas, autoimmune diseases and infectious diseases. Co.'s lead product candidate is mupadolimab, a humanized monoclonal antibody that is designed to react with a specific site on CD73. Co.'s next product candidate, CPI-818, is a selective, covalent inhibitor of ITK and is in a multi-center Phase 1/1b clinical trial in patients with various malignant T-cell lymphomas. Co.'s third product candidate, ciforadenant, is an oral, small molecule antagonist of the A2A receptor for adenosine. | |
|
Corvus Pharmaceuticals (CRVS) has the following price history information. Looking back at CRVS historical stock prices for the last five trading days, on April 19, 2024, CRVS opened at $1.40, traded as high as $1.44 and as low as $1.36, and closed at $1.40. Trading volume was a total of 58.80K shares. On April 22, 2024, CRVS opened at $1.39, traded as high as $1.50 and as low as $1.39, and closed at $1.44. Trading volume was a total of 130.60K shares. On April 23, 2024, CRVS opened at $1.43, traded as high as $1.57 and as low as $1.43, and closed at $1.53. Trading volume was a total of 137.40K shares. On April 24, 2024, CRVS opened at $1.60, traded as high as $1.60 and as low as $1.49, and closed at $1.51. Trading volume was a total of 90.60K shares. On April 25, 2024, CRVS opened at $1.47, traded as high as $1.52 and as low as $1.41, and closed at $1.48. Trading volume was a total of 66.30K shares.
CRVS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Corvus Pharmaceuticals shares, starting with a $10,000 purchase of CRVS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/24/2016 |
|
End date: |
04/25/2024 |
|
Start price/share: |
$14.25 |
|
End price/share: |
$1.48 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-89.61% |
|
Average Annual Total Return: |
-24.41% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1,038.47 |
|
Years: |
8.09 |
|
|
|
Date |
Close |
04/19/2024 | $1.40 | 04/22/2024 | $1.44 | 04/23/2024 | $1.53 | 04/24/2024 | $1.51 | 04/25/2024 | $1.48 |
|
|